Skip to main content

News and Media Releases

In the News

Media Releases

ABcann aiming for Consistency
ABcann Global, a Canadian licensed medical marijuana producer, began trading on the Venture in May. We check in with Aaron Keay, CEO with ABcann Global, on how the company intends to scale up production.
BNN - Wednesday August 30, 2017
ABcann & Cannabis Wheaton Sign Win-Win Deal to Expand Production
CFN Media Group today announced publication of an article covering ABcann Global Corp.'s binding interim agreement with Cannabis Wheaton Income Corp.
CFN Media Group - Friday June 02, 2017
Time to Invest in ABcann Global (TSX-V: ABCN)
Some said it would be the biggest legal cannabis IPO of the year...
Wealth Daily - Wednesday May 31, 2017
ABcann’s Pesticide-Free Approach is a Breath of Fresh Air
The industry continues to struggle with safety concerns, such as the use of banned pesticides...
CFN Media Group - Tuesday May 23, 2017
Boom Time Ahead For Licensed Producers Of Medical Marijuana
ABcann Medicinals, one of Canada's first medical-marijuana producers to be licensed under federal regulations, is going public.
Financial Post - Friday. Mar. 17, 2017
Pharmaceutical Grade, Standardized Licensed Producer Poised to Go Public
Canada's legal cannabis industry could generate $22.6 billion in annual revenue, which has created significant opportunities for investors...
CFN Media Group - March, 2017
Cannabis Producer Growing
A Napanee company taking a high-tech approach to producing medical cannabis is going public in an effort to finance its rapid expansion...
Kingston Whig-Standard - February 17, 2017

ABcann Global Receives $11.9 Million from Exercise of Warrants

September 18,2017

ABcann Global Appoints Barry Fishman as Chief Executive Officer

September 7,2017

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

August 30, 2017

ABcann Global files Q2 2017 Financial Results and Provides Operational Update

August 30, 2017

Management’s Discussion and Analysis

August 30, 2017

ABcann RELEASES HIGH LEVEL CBD PRODUCT AND LAUNCHES INITIAL OILS STRATEGY

August 28, 2017

ABcann GLOBAL PROVIDES CONSTRUCTION AND EXPANSION UPDATE

July 26, 2017

ABcann GLOBAL ANNOUNCES LISTING ON THE OTCQB MARKETPLACE AND THE FRANKFURT STOCK EXCHANGE

July 12, 2017

ABcann AND CANNABIS WHEATON ANNOUNCE SIGNING OF AGREEMENT FOR FIRST TRANCHE $15 MILLION INVESTMENT

July 10, 2017

ABcann GLOBAL ANNOUNCES INCLUSION ON THE HORIZONS MEDICAL MARIJUANA LIFE SCIENCES ETF

July 5, 2017

ABcann GLOBAL RECRUITS DR. MICHAEL SHANNON AS CHIEF MEDICAL CONSULTANT

June 29, 2017

ABcann GLOBAL EXTENDS RESEARCH AGREEMENT WITH THE UNIVERSITY OF GUELPH

June 26, 2017

ABcann GLOBAL AND CANNABIS WHEATON SIGN INTERIM AGREEMENT FOR CONSTRUCTION OF ADDITIONAL CANNABIS CULTIVATION FACILITY

May 29, 2017

ABcann GLOBAL ANNOUNCES APPOINTMENT OF W. BRETT WILSON TO ADVISORY BOARD

May 3, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE MULTI-STAGE PRODUCT TESTING METHODOLOGY

April 24, 2017

PANDA AND ABcann MEDICINALS ANNOUNCE CONDITIONAL APPROVAL OF QUALIFYING TRANSACTION

March 30, 2017

PANDA AND ABcann MEDICINALS PROVIDE UPDATE ON QUALIFYING TRANSACTION AND ANNOUNCE $8 MILLION BROKERED FINANCING AND $15 MILLION NON-BROKERED FINANCING

March 23, 2017

PANDA ANNOUNCES PROPOSED QUALIFYING TRANSACTION WITH ABcann MEDICINALS INC

December 2, 2016
Read our: Code Of Business Conduct | Insider Trading Policy | Whistleblower Protection Policy